Key Market Indicator:
Welcome our new Research Provider
In the Research & Ratings section, you can access assessments from renowned analyst firms that specialize in the due diligence and valuation of companies that are generally listed on the stock exchange. Starting from the research reports, you can access further research tools and information with just a few mouse clicks, which offer you additional options for obtaining and assessing information.
Wed, 11.11.2026       NFON AG

Company Name: NFON AG ISIN: DE000A0N4N52   Reason for the research: Update Recommendation: BUY Target price: EUR 5 Target price on sight of: 12 months Last rating change: Analyst: Philipp Sennewald Q3 preview: Seat decline to continue, margin to recover On 19 November, NFON will publish its Q3 report. We expect another decline on [ … ]
Wed, 11.11.2026       Emerald Horizon AG

Company Name: Emerald Horizon AG ISIN: AT0000A3UZE1   Reason for the research: Update Recommendation: BUY Target price: EUR 1,300 Target price on sight of: 12 months Last rating change: Analyst: Jorge Gonzalez € 135m equity plan could pave the way for institutional fundingEmerald Horizon plans to raise c. € 135m through [ … ]
Mon, 09.11.2026       EBRO MOTORS GROUP EV SA

Company Name: EBRO MOTORS GROUP EV SA ISIN: ES0105725008   Reason for the research: Update Recommendation: BUY Target price: EUR 16.50 Target price on sight of: 12 months Last rating change: Analyst: Jorge Gonzalez € 200m financing paves the way for further growthEBRO Motors has announced a financing facility of up to c. &eu [ … ]
Fri, 06.11.2026       https://research-hub.de/companies/stabilus-se

Stabilus delivered a strong preliminary Q4, with revenue and adjusted EBIT exceeding consensus by 13% and 32%, respectively. However, a EUR 67m non-cash goodwill impairment in the Americas reduced reported FY26 EBIT to EUR 63.7m. Excluding this charge, EBIT of EUR 131m almost exactly matched our previous forecast. Management also lowered its 2030 revenue target from EUR 2.0bn to EUR 1.5bn, confirming our longstanding concerns about growth prospects. We fine-tune near-term estimates following the strong Q4 but lower long-term assumptions, as structural headwinds in the automotive sector continue to limit recovery potential. Consequently, we cut our price target to EUR 15.00 (EUR 17.80) and downgrade to HOLD (BUY). The full update can be downloaded under https://research-hub.de/companies/stabilus-se
Fri, 06.11.2026       https://research-hub.de/companies/viromed-medical-ag

Viromed Medical AG has raised EUR 2.0m in gross proceeds through a capital increase to strengthen working capital during the commercial ramp-up of ViroCAP. In parallel, the company has achieved important operational milestones, including regulatory approval for ViroCAP med in Turkey several months ahead of schedule and its first reimbursement agreement with a German statutory health insurer. The Turkish approval clears the way for deliveries against binding minimum orders of 7,000 devices through FY28, while the reimbursement agreement represents an important step towards broader clinical adoption. Although initial production delays lead us to lower our FY26 revenue and earnings estimates, recent developments strengthen confidence in the anticipated FY27 ramp-up. And the long-term investment thesis for cold atmospheric plasma technology remains intact. We maintain our BUY rating and EUR 11.00 price target. The full update can be downloaded under https://research-hub.de/companies/viromed-medical-ag
Fri, 06.11.2026       https://research-hub.de/companies/kontron-ag

Kontron's Q3 results presented a mixed picture, with solid underlying growth (excl. Greentec) and improving adj. profitability overshadowed by persistent supply-chain constraints. Delayed orders continued to accumulate, making the confirmed FY26 guidance increasingly challenging despite strong demand. Meanwhile, GreenTec restructuring has been completed, and increasingly tangible Ennoconn synergies underpin the expected earnings recovery from 2027. We lower our FY26 revenue and earnings estimates and slightly moderate our 2027-28 sales forecasts, while largely maintaining medium-term earnings expectations. Although the ongoing disconnect between order intake and revenue conversion remains unsatisfactory, we believe the investment case remains intact. BUY; PT EUR 34.00 (old: EUR 35.00). The full update can be downloaded under https://research-hub.de/companies/kontron-ag
Fri, 06.11.2026       https://research-hub.de/companies/indus-holding-ag

INDUS Holding is scheduled to report Q3 2026 results on November 12. We expect another solid quarter, with revenue increasing ~16% yoy to EUR 505m (consensus: EUR 511.6m) and EBITDA rising 19% yoy to EUR 79.7m, implying a margin of 15.8% (+49bp yoy). EBIT should improve 24% yoy to EUR 53.7m (consensus: EUR 53.9m), although profitability is expected to normalize sequentially following the exceptional Q2 performance. While the tungsten carbide windfall in Materials Solutions should continue supporting earnings, improving underlying momentum in Engineering and Infrastructure provides additional confidence in our view. We maintain our constructive view on INDUS, supported by its solid order backlog, strengthening core portfolio and attractive valuation. BUY, PT EUR 43.00. The full update can be downloaded under https://research-hub.de/companies/indus-holding-ag
Fri, 06.11.2026       https://research-hub.de/companies/h2apex-group-sca

H2APEX is transforming from an EPC service provider into an integrated green hydrogen producer, aiming to capture more value across the hydrogen value chain. The company is expected to return to growth in FY26, with revenue guidance of EUR 14–16m following a 67.5% yoy increase to EUR 7.0m in H1 2026. Its growth strategy centres on five decentralised 5 MW projects and larger facilities, including SPARK, SKY and WAL in Lubmin, which could drive a significant scale-up from 2028/2029 onwards. EUR 167m in IPCEI funding for WAL supports project development, while Germany’s expanding hydrogen infrastructure and industrial demand provide long-term opportunities. However, financing requirements, project execution and market development remain key risks. We reiterate our Spec. BUY rating with a price target of EUR 2.70 offering an upside potential of 194.8%. The full update can be downloaded under https://research-hub.de/companies/h2apex-group-sca
Fri, 06.11.2026       https://research-hub.de/companies/123fahrschule-se

123fahrschule (123fs) is entering a new strategic phase. A potential partnership with mVISE combines fresh capital with software expertise and B2B capabilities, a compelling Smart Money proposition. Together, both companies aim to develop 123fs’ proprietary platform into a scalable licensing solution for independent driving schools, adding capital-light growth opportunities. Meanwhile, the Bundestag’s approval of key driving license reform measures removes major regulatory hurdles, supporting 123fs’ digital-first strategy. With Ralf Thomas replacing founder Boris Polenske, who remains a shareholder, new leadership, potential capital and an expanded business model mark a solid strategic reset. We reiterate BUY and EUR 5.20 PT. The full update can be downloaded under https://research-hub.de/companies/123fahrschule-se
Fri, 06.11.2026       https://research-hub.de/companies/daimler-truck-holding-ag

Daimler Truck delivered a strong Q3, although results came in below our expectations, with revenue up 19% yoy to EUR 12.6bn and adj. EBIT rising 73% to EUR 1.1bn. Trucks North America was the key growth driver, supported by higher volumes, efficiency measures and US tariff refunds, while Mercedes-Benz Trucks also improved its performance. Incoming orders rose 10% yoy, reflecting an improving market environment but also catch-up and pull-forward effects. Despite the recovery, demand visibility remains limited amid geopolitical tensions, elevated energy prices and high interest rates. Moreover, growing competition from Chinese electric truck manufacturers could structurally pressure pricing power. Over the longer term, European OEMs may therefore face a strategic trade-off between defending margins and protecting market share, potentially forcing DTG to make difficult pricing decisions to remain competitive. We therefore reiterate our SELL rating with a PT of EUR 33.00. The full update can be downloaded under https://research-hub.de/companies/daimler-truck-holding-ag

Gamechanger in online marketing · Innovation as a service · Upgrade your own internet presence.

© 2026 Select Sector SPDRs

* * *

More Sector related Investment Ideas
© 2026 WEBs Investments ETFs
Legend/Explanation
The newswire feed is updated several times a day. To make sure you don't miss any news, please check back here often. If you are curious about a headline or want to find out more about a publication, click on it to go to the preview and click again to go to the full news item.
Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Sunday, 22.11.2026, Calendar Week 47, 326th day of the year, 39 days remaining until EoY.